ALT
Price
$3.64
Change
-$0.05 (-1.36%)
Updated
Sep 12 closing price
Capitalization
321.26M
59 days until earnings call
VKTX
Price
$24.81
Change
-$0.93 (-3.61%)
Updated
Sep 12 closing price
Capitalization
2.79B
39 days until earnings call
Interact to see
Advertisement

ALT vs VKTX

Header iconALT vs VKTX Comparison
Open Charts ALT vs VKTXBanner chart's image
Altimmune
Price$3.64
Change-$0.05 (-1.36%)
Volume$1.76M
Capitalization321.26M
Viking Therapeutics
Price$24.81
Change-$0.93 (-3.61%)
Volume$4.06M
Capitalization2.79B
ALT vs VKTX Comparison Chart in %
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. VKTX commentary
Sep 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and VKTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 14, 2025
Stock price -- (ALT: $3.64 vs. VKTX: $24.81)
Brand notoriety: ALT and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 58% vs. VKTX: 61%
Market capitalization -- ALT: $321.26M vs. VKTX: $2.79B
ALT [@Biotechnology] is valued at $321.26M. VKTX’s [@Biotechnology] market capitalization is $2.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALT and VKTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 2 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • ALT’s TA Score: 2 bullish, 4 bearish.
  • VKTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than ALT.

Price Growth

ALT (@Biotechnology) experienced а -3.70% price change this week, while VKTX (@Biotechnology) price change was -8.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.38%. For the same industry, the average monthly price growth was +7.84%, and the average quarterly price growth was +35.14%.

Reported Earning Dates

ALT is expected to report earnings on Nov 11, 2025.

VKTX is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (+1.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($2.79B) has a higher market cap than ALT($321M). VKTX YTD gains are higher at: -38.345 vs. ALT (-49.515). ALT has higher annual earnings (EBITDA): -88.03M vs. VKTX (-212.42M). VKTX has more cash in the bank: 808M vs. ALT (183M). VKTX has less debt than ALT: VKTX (878K) vs ALT (15.8M). ALT has higher revenues than VKTX: ALT (20K) vs VKTX (0).
ALTVKTXALT / VKTX
Capitalization321M2.79B12%
EBITDA-88.03M-212.42M41%
Gain YTD-49.515-38.345129%
P/E RatioN/AN/A-
Revenue20K0-
Total Cash183M808M23%
Total Debt15.8M878K1,800%
FUNDAMENTALS RATINGS
ALT vs VKTX: Fundamental Ratings
ALT
VKTX
OUTLOOK RATING
1..100
1160
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
10081
SMR RATING
1..100
9895
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALT's Valuation (50) in the Miscellaneous Commercial Services industry is in the same range as VKTX (50) in the Biotechnology industry. This means that ALT’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's Profit vs Risk Rating (81) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that VKTX’s stock grew similarly to ALT’s over the last 12 months.

VKTX's SMR Rating (95) in the Biotechnology industry is in the same range as ALT (98) in the Miscellaneous Commercial Services industry. This means that VKTX’s stock grew similarly to ALT’s over the last 12 months.

VKTX's Price Growth Rating (50) in the Biotechnology industry is in the same range as ALT (50) in the Miscellaneous Commercial Services industry. This means that VKTX’s stock grew similarly to ALT’s over the last 12 months.

VKTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that VKTX’s stock grew similarly to ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTVKTX
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 16 days ago
81%
Bullish Trend 17 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EVTMX17.39N/A
N/A
Eaton Vance Dividend Builder A
IHGIX36.45N/A
N/A
Hartford Dividend and Growth A
CHCLX12.32N/A
N/A
AB Discovery Growth A
MNMIX15.10N/A
N/A
Manning & Napier Pro-Blend Mod Term I
PWDIX10.45N/A
N/A
Donoghue Forlines Dividend I

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with NEVPF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-3.61%
NEVPF - VKTX
45%
Loosely correlated
N/A
SYRE - VKTX
41%
Loosely correlated
-3.40%
GPCR - VKTX
41%
Loosely correlated
+0.14%
CRVS - VKTX
38%
Loosely correlated
-3.80%
LRMR - VKTX
38%
Loosely correlated
-5.76%
More